References
- Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017; 376:2556–65.
- Jayashankar CA, Avinash S, Shashidharan B, Sarathi V, Shruthi KR, Nikethan D, et al. The prevalence of anti-thyroid peroxidase antibodies in subclinical and clinical hypothyroid patients. Int J Res Med Sci. 2015; 3:3564–6.
- Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab. 2014; 99:2372–82.
- Malhotra Y, Kaushik RM, Kaushik R. Echocardiographic evaluation of left ventricular diastolic dysfunction in subclinical hypothyroidism: a case–control study. Endocr Res. 2017; 42:1–11.
- Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005; 105:239–45.
- Goichot B, Luca F. Dysthyroïdies infracliniques. Press Medicale. 2011; 40:1132–40.
- Mohanty S, Amruthlal W, Reddy G, Kusumanjali G, Kanagasabapathy A, Rao P. Diagnostic strategies for subclinical hypothyroidism. Indian J Clin Biochem. 2008; 23:279–82.
- Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992; 92: 631–42.
- Zulewski H, Müller B, Exer P, Miserez AR, Staub J-J. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997; 82:771–6.
- Meier C, Christ-Crain M, Guglielmetti M, Huber P, Staub J-J, Müller B. Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy. Thyroid. 2003; 13:979–85.
- Sharma LK, Sharma N, Gadpayle AK, Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur J Intern Med. 2016; 35:106–10.
- Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005; 90:5483–8.
- Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009; 84:65–71.
- Cooper D. Subclinical hypothyroidism. JAMA. 1987; 258:246–7. doi:10.1001/jama.1987.03400020088037
- Lum S, Nicoloff J, Spencer C, Kaptein EM. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J Clin Invest. 1984; 73:570–5.
- Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National health and nutrition examination survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab. 2007; 92:4236–40.
- Huber G, Staub J-J, Meier C, Mitrache C, Guglielmetti M, Huber P, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002; 87:3221–6.
- Mcdermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab. 2001; 86:4585–90.
- Reuters VS, Buescu A, Reis FAA, Almeida CP, Teixeira PF dos S, Costa AJL, et al. [Clinical and muscular evaluation in patients with subclinical hypothyroidism]. Arq Bras Endocrinol Metabol. 2006; 50:523–31.
- Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984; 101:18–24.
- Goel P, Narang S, Gupta BK, Goel K. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism. J Clin Diagnostic Res. 2015; 9:15–7.
- Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med. 2002; 112:348–54.
- Roos A, Links TP, de Jong-van den Berg LTW, Gans ROB, Wolffenbuttel BHR, Bakker SJL. Thyroid peroxidase antibodies, levels of thyroid stimulating hormone and development of hypothyroidism in euthyroid subjects. Eur J Intern Med. 2010; 21:555–9.
- Jensen E, Petersen PH, Blaabjerg O, Hansen PS, Brix TH, Kyvik KO, et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med. 2004; 42:824–32.
- Li Y, Teng D, Shan Z, Teng X, Guan H, Yu X, et al. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab. 2008; 93:1751–7.
- Bahar A, Akha O, Kashi Z, Vesgari Z. Hyperprolactinemia in association with subclinical hypothyroidism. Casp J Intern Med. 2011; 2:229–33.
- Ghoraishian SM, Hekmati Moghaddam SH, Afkhami-Ardekani M. Relationship between anti-thyroid peroxidase antibody and thyroid function test. Iran J Immunol. 2006; 3:146–9.
- Al-Hilali KA. Prevalence of hypovitaminosis D in adult Iraqi people including postmenopausal women. Sci Res J. 2016; IV:53–62.
- Aboud S, Al-Tu’ma F, Abd Alkarem L. Deficiency of vitamin D and iron in anemic female Iraqi patients. Int J Pharm Pharm Sci. 2017; 8:87–96.